Biovance Capital Partners is a Lisbon-based venture capital firm established in 2023-2024 that manages Biovance Capital Fund I (≈€50-60 million). The firm invests at seed and Series A stages in early-stage biotech and biopharma companies across Europe, backing teams developing innovative therapeutics for a wide range of disease areas.
Focus Areas
Notable Investments
